Income (Loss) Per Share (Tables)

3 Months Ended

Mar. 31, 2024

Earnings Per Share [Abstract]

Schedule of Income (Loss) Per Share

	Three Months Ended March 31,
(In thousands, except per share data)	2024		2023
Numerator:
Net loss from continuing operations	$	(11,879)	$	(13,733)
Net income from discontinued operations, net of tax	37,300		6,098
Net income (loss)	25,421		(7,635)
Less: net income attributable to noncontrolling interests	—		448
Net income (loss) attributable to UpHealth, Inc.	$	25,421	$	(8,083)
Denominator:
Weighted average shares outstanding - basic and diluted	18,699		15,730
Net income (loss) per share - basic and diluted
Continuing operations	$	(0.64)	$	(0.87)
Discontinued operations, net of tax	$	1.99	$	0.39
Attributable to UpHealth, Inc.	$	1.36	$	(0.51)

Schedule of Calculation of Income (Loss) Per Share

The calculation of income (loss) per share excluded the following because the effect would be anti-dilutive:

	Three Months Ended March 31,
(In thousands, except per share data)	2024	2023
2021 Public, Private and PIPE Warrants at a $115.00 per share conversion price	1,812	1,812
2023 Private Placement Series A and B Warrants at a $2.04 per share conversion price	6,000	6,000
Stock options	1,348	138
Restricted stock units	1,296	1,342
2025 Notes at a $17.50 per share conversion price(1)	3,270	3,857
2026 Notes at a $106.50 per share conversion price	1,080	1,080

(1) Subject to the occurrence of certain corporate events.